YOUNGIL KIM

Dr. YOUNGIL KIM


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
LZLiqing Zang
Liqing Zang
Yasuhito ShimadaYasuhito Shimada
Yasuhito Shimada
NHNakayama Hiroko
Nakayama Hiroko
HKHirotaka Katsuzaki
Hirotaka Katsuzaki
YKYOUNGIL KIM
YOUNGIL KIM
NNnorihiro nishimura
norihiro nishimura
Various natural products (NPs) have been used to treat obesity and related diseases. However, the best way to fight obesity is preventive, with accurate body weight management through exercise, diet, or bioactive NPs to avoid obesity development. We demonstrated that green tea extract (GTE) is an anti-obesity NP using a zebrafish obesity model. Based on a hypothesis that GTE can prevent obesity, the objective of this study was to assess GTE’s ability to attenuate obesity development. Juvenile zebrafish were pretreated with GTE for seven days before obesity induction via a high-fat diet; adult zebrafish were pretreated with GTE for two weeks before obesity induction by overfeeding. As a preventive intervention, GTE significantly decreased visceral adipose tissue accumulation in juveniles and ameliorated visceral adiposity and plasma triglyceride levels in adult zebrafish obesity models. RNA sequencing analysis was performed using liver tissues from adult obese zebrafish, with or without GTE administration, to investigate the underlying molecular mechanism. Transcriptome analysis revealed that preventive GTE treatment affects several pathways associated with anti-obesity regulation, including activation of STAT and downregulation of CEBP signaling pathways. In conclusion, GTE could be used as a preventive agent against obesity.

3 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
XLXuan Li
Xuan Li
HYHiroaki Yamada
Hiroaki Yamada
SMSayo Morita
Sayo Morita
YYYusuke Yamashita
Yusuke Yamashita
YKYOUNGIL KIM
YOUNGIL KIM
MKMujo Kim
Mujo Kim
A great number of chemically diverse pancreatic lipase (PL) inhibitors have been identified to tackle obesity; however, very few of them have entered clinical studies. The ethanolic extract of sesame meal is a potent PL inhibitor, and its activity hinges exclusively on two free fatty acids: linoleic acid and oleic acid, which were proven to reduce postprandial triglyceride excursion in rats. Herein, to investigate the clinical efficacy of the sesame meal extract, in a crossover trial, 30 healthy volunteers were randomized to receive the sesame meal extract containing experimental food or placebo along with a high-fat meal. Treatment with the sesame meal extract significantly lowered the incremental postprandial serum triglyceride concentration and reduced the incremental area under the curve (iAUC) by 16.8% (p-value = 0.03) compared to placebo. Significant decreases in postprandial remnant-like lipoprotein particle cholesterol and low-density lipoprotein particles were also observed, whereas high-density lipoprotein cholesterol was increased. These results suggest that treatment with the sesame meal extract significantly reduced the postprandial excursion of triglycerides and improved the lipidemic profile after high dietary fat intake in healthy individuals, indicating the substantial potential of free linoleic acid and oleic acid and natural products rich in these compounds for the management of obesity and related conditions.

30 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
YHYoshihiro Hara
Yoshihiro Hara
UNUtano Nakamura
Utano Nakamura
KKKeita Koga
Keita Koga
YYYusuke Yamashita
Yusuke Yamashita
YKYOUNGIL KIM
YOUNGIL KIM
RFRyousuke Furukado
Ryousuke Furukado
Objective: This study focused on the effect of γ-aminobutyric acid (GABA) intake on psychological state and game performance during esports gameplay. Methods: A randomized, double-blind, placebo-controlled crossover study was conducted with eight healthy male university students aged 20–24 years who regularly play esports. The participants ingested either 200 mg of GABA or a placebo prior to gameplay and then completed a standardized esports task using the Mobalytics Proving Ground™ (MPG), a perceptual-cognitive task within “League of Legends” designed to train and evaluate player performance. Subjective psychological states were assessed pre- and post-gameplay using the Profile of Mood States 2 (POMS2®) short version. Esports task performance was evaluated based on MPG scores. Results: GABA intake significantly reduced psychological confusion–bewilderment and fatigue in the POMS 2® short version during esports gameplay. Furthermore, the game scores were significantly higher in the GABA group compared to the placebo group. Conclusions: These findings suggest that GABA intake may serve as a potential strategy to enhance both the mental state and performance of esports players.

3 July 2024 in Nutraceuticals
Verified
Journal Article
Open access
PDF file
ARArif Yanuar Ridwan
Arif Yanuar Ridwan
YSYuki Shimozu
Yuki Shimozu
NNNikesh Narang
Nikesh Narang
TKTakashi Kometani
Takashi Kometani
YYYusuke Yamashita
Yusuke Yamashita
YKYOUNGIL KIM
YOUNGIL KIM
Jabuticaba fruit (Plinia cauliflora) is widely consumed in various forms such as juice, jam, wine, and liquors; however, its potential therapeutic effects on diabetic complications remain inadequately explored. We aimed to investigate the potential antiglycation activity of Jabuticaba, identify the active compounds through bioassay-guided fractionation, and assess its effects on cataract formation in a Streptozotocin-induced diabetic type 1 rat model. Through bioassay-guided fractionation, we identified gallic acid (IC50: 24.7 µg/mL), protocatechuic acid (IC50: 1.22 µg/mL), and an ellagitannin, Repandinin B (IC50: 0.55 µg/mL), as active compounds contributing to antiglycation effects. In the animal study, the addition of Jabuticaba juice extract to the drinking water at a concentration of 0.5% (w/v) for 12 weeks demonstrated an amelioration in cataract progression. These results suggest that Jabuticaba has high antiglycation effects leading to the delaying of cataract formation in type 1 diabetes.

1 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAngga Sanjaya
Angga Sanjaya
AIAkiko Ishida
Akiko Ishida
XLXuan Li
Xuan Li
YKYugweng Kim
Yugweng Kim
HYHiroaki Yamada
Hiroaki Yamada
YKYOUNGIL KIM
YOUNGIL KIM
Background: Our search for plant-derived ceramides from sustainable sources led to the discovery of ceramides and glucosylceramides in wine lees. Objective: This study evaluated the efficacy and safety of wine lees extract (WLE)-derived ceramides and glucosylceramides in enhancing skin barrier function. Methods: A randomized, double-blind, placebo-controlled study was conducted with 30 healthy Japanese subjects aged 20–64. Subjects were allocated to receive either the WLE-derived ceramides and glucosylceramides (test group) or placebo for 12 weeks. The primary outcome was transepidermal water loss (TEWL), and secondary outcomes included skin hydration, visual analog scale (VAS) of itching sensation, and the Japanese Skindex-29. Results: One participant withdrew for personal reasons, resulting in 29 subjects for data analysis (placebo n = 15; test n = 14). The test group showed a tendency of lower TEWL compared to the placebo after 8 weeks (p = 0.07). Furthermore, after 12 weeks of administration, the test group had significantly lower TEWL than the placebo (p = 0.04). On the other hand, no significant differences were observed in the secondary outcome parameters. No adverse events related to the supplements were reported. Conclusions: Oral supplementation of WLE-derived ceramides and glucosylceramides is a prominent and safe approach to enhancing skin barrier function and health. Trial registration: (UMIN000050422).

1 April 2026 in Toxicology Reports
Verified
Journal Article
Open access
XLXuan Li
Xuan Li
AKAditya Kulkarni
Aditya Kulkarni
HYHiroaki Yamada
Hiroaki Yamada
YYYusuke Yamashita
Yusuke Yamashita
YKYOUNGIL KIM
YOUNGIL KIM
Gamma-aminobutyric acid (GABA) occurs naturally in a variety of foods and has a long history of dietary consumption, yet its effects on reproduction and development have not been evaluated in a guideline-compliant toxicological study. We examined the reproductive and developmental endpoints of repeated oral gavage GABA administration in Sprague Dawley (SD) rats using an enhanced OECD (Organization for Economic Co-operation and Development) 421–compliant design, in which groups of 20 males and 20 females received daily doses of 0, 625, 1250, or 2500 mg/kg/day GABA. The OECD 421 protocol was modified to include male dosing lasting 89–92 days, covering the pre-mating, mating, and post-mating periods. Females were dosed for 50–63 days from pre-mating through Lactation Day 12, with protocol-based adjustments for reproductive status. No treatment-related mortality, systemic toxicity, or organ pathology was observed. Estrous cyclicity, mating performance, fertility index, implantation, gestation, parturition, and maternal behavior remained unchanged. Offspring viability and developmental landmarks showed no treatment-related differences. Hormonal assessments revealed no pattern indicative of reproductive or thyroid disruption. Overall, repeated oral GABA administration in SD rats up to 2500 mg/kg/day produced no adverse effects on parental health, reproductive outcomes, or offspring development.